Publications by authors named "Callum M Sloss"

Claim this Profile
H
Heterogeneity and Scoring Reproducibility of Folate Receptor 1 Immunohistochemistry in High-grade Serous Carcinoma.
Brooke Liang, Troy B Tenney, Lucy Han, Xiaoming Zhang, Aihui Wang, Callum M Sloss

Int J Gynecol Pathol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Laboratory-Derived Immunohistochemical Assays for Folate Receptor α Expression in Epithelial Ovarian Cancer and Comparison With a Companion Diagnostic.
Emily Deutschman, Regan Fulton, Callum M Sloss

Arch Pathol Lab Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response relationships of mirvetuximab soravtansine in patients with folate receptor-α-positive ovarian cancer: Justification of therapeutic dose regimen.
Ya-Ping Tu, H Maxime Lagraauw, Michael Method, Yuemei Wang, Eva Hanze, Callum M Sloss

Br J Clin Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an FRα Companion Diagnostic Immunohistochemical Assay for Mirvetuximab Soravtansine.
Racheal L James, Taryn Sisserson, Zhuangyu Cai, Megan E Dumas, Landon J Inge, Callum M Sloss

Arch Pathol Lab Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Naval G Daver, Pau Montesinos, Daniel J DeAngelo, Eunice S Wang, Nikolaos Papadantonakis, Callum M Sloss

Lancet Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor-α positive ovarian cancer: The antibody-drug conjugate, payload and metabolite.
Ya-Ping Tu, Eva Hanze, Fengying Zhu, H Maxime Lagraauw, Callum M Sloss

Br J Clin Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models.
Stuart W Hicks, Chiara Tarantelli, Alan Wilhem, Eugenio Gaudio, Min Li, Callum M Sloss

Haematologica· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMGN779, a Novel CD33-Targeting Antibody-Drug Conjugate with DNA-Alkylating Activity, Exhibits Potent Antitumor Activity in Models of AML.
Yelena Kovtun, Paul Noordhuis, Kathleen R Whiteman, Krystal Watkins, Gregory E Jones, Callum M Sloss

Mol Cancer Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models.
Stuart W Hicks, Katharine C Lai, L Cristina Gavrilescu, Yong Yi, Surina Sikka, Callum M Sloss

Neoplasia· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic.
Jeffrey D Kearns, Raghida Bukhalid, Mark Sevecka, Gege Tan, Nastaran Gerami-Moayed, Callum M Sloss

Mol Cancer Ther· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana.
Mashael S Al-Mutairi, Laurence C Cadalbert, H Adrienne McGachy, Muhannad Shweash, Juliane Schroeder, Callum M Sloss

PLoS Pathog· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function.
Andrea Boni, Alexandria P Cogdill, Ping Dang, Durga Udayakumar, Ching-Ni Jenny Njauw, Callum M Sloss

Cancer Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation of MAP kinase activation by a novel splice variant of human MAP kinase phosphatase-2.
Laurence C Cadalbert, Callum M Sloss, Margaret R Cunningham, Mashael Al-Mutairi, Alan McIntire

Cell Signal· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells.
Callum M Sloss, Fang Wang, Rong Liu, Lijun Xia, Michael Houston

Clin Cancer Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-protein-dependent and -independent pathways regulate proteinase-activated receptor-2 mediated p65 NFkappaB serine 536 phosphorylation in human keratinocytes.
Fui Goon Goh, Callum M Sloss, Margaret R Cunningham, Mary Nilsson, Laurence Cadalbert

Cell Signal· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase.
Laurence Cadalbert, Callum M Sloss, Pamela Cameron, Robin Plevin

Cell Signal· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of two putative nuclear localization sequences is required for cytosolic localization of mitogen-activated protein kinase phosphatase-2.
Callum M Sloss, Laurence Cadalbert, Stephen G Finn, Stephen J Fuller, Robin Plevin

Cell Signal· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes.
Scott R Macfarlane, Callum M Sloss, Pamela Cameron, Toru Kanke, Roderick C McKenzie

Br J Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis